Xcout IntelSign inSubscribe

Tvaster Genkalp competitors & alternatives

Therapeutic DevicesIndia

The 11 closest competitors and alternatives to Tvaster Genkalp among therapeutic devices companies — ranked by similarity to what Tvaster Genkalp actually does, not by market-cap band.

11Competitors listed

Subscribe to see Tvaster Genkalp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Tvaster Genkalp

Tvaster Genkalp Pvt. Ltd. is a molecular diagnostics company established in May 2021 and headquartered in Chennai, Tamil Nadu. The company specializes in liquid biopsy, offering blood-based cancer diagnostic solutions.

Tvaster Genkalp at a glance

Tvaster Genkalp is a therapeutic devices company headquartered in India. Its most recent funding round, Pre-Series A, raised $1.3M in April 2025. Xcout tracks 2 named people at Tvaster Genkalp, including K. Sreedurgalakshmi (co-founder).

Tvaster Genkalp leadership

  • K. Sreedurgalakshmico-founder
  • Srikar Ramanco-founder

Tvaster Genkalp funding rounds

Every round on record:

DateRoundAmountInvestors
Pre-Series A$1.3M4 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 11 Tvaster Genkalp competitors

Ranked by semantic similarity — how close each company is to Tvaster Genkalp by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

ANGLE plcMedical DevicesGuildford, United States
63% match

Medical Devices

CelLBxHealth plc, formerly known as ANGLE plc until its name change in October 2025, is a medical diagnostics enterprise established in 1994 and headquartered in Guildford, United Kingdom. The company is dedicated to developing advanced cancer diagnostic products, serving markets across the United Kingdom, Europe, North America, and other international regions. Its core offerings include the Parsortix PC1 and PR1 systems, which are innovative medical devices engineered to capture and retrieve intact circulating tumor cells (CTCs) from patient blood. Specifically, the PC1 system is designed for metastatic breast cancer samples, facilitating subsequent user-validated downstream analysis. CelLBxHealth also provides the Portrait+ CTC Staining kit, a laboratory solution for the identification, characterization, and enumeration of epithelial and mesenchymal CTCs with high analytical sensitivity and specificity, alongside the CellKeep Slide technology for CTC harvesting. In addition to these products, the company delivers a suite of laboratory services, including CTC enrichment and liquid biopsy analysis. Specialized assays are also available, such as Portrait Flex for immunofluorescence-based identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition, Portrait PD-L1 for CTC evaluation, and bespoke custom CTC assays. Furthermore, CelLBxHealth plc has forged strategic alliances, including a partnership with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. for the application of its pan-cancer next-generation sequencing (NGS) panel.

Valuation—
Employees—
ANGLE plc competitors & alternatives →
BIO VIEWBIOV · Medical DevicesRehovot, Israel
61% matchPublic

Medical Devices

Bio-View Ltd, founded in 2000 and headquartered in Rehovot, Israel, is a developer, manufacturer, and global distributor of advanced automated cell imaging and analysis systems. These sophisticated solutions are utilized by clinical and research laboratories worldwide, specifically in the fields of cytology, cytogenetics, and pathology. The company's extensive product lineup includes: Accord: A semi-automated fluorescent imaging and analysis workbench microscope station. Accord Plus: An automatic fluorescent imaging system capable of real-time scanning, analysis, and sorting of diverse FISH (Fluorescence In Situ Hybridization) samples. Allegro Plus: Another automatic fluorescent imaging system engineered to pinpoint various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. DUET-3: An imaging and analysis platform featuring an automated barcode reader, which streamlines the processing of multiple test types within a single scan batch. DeNovo: An automated scanning system dedicated to the precise detection, analysis, and characterization of circulating tumor cells found in peripheral blood. Solo Workstation & Solo Touch Workstation: These are offline and standalone workstations, respectively, providing advanced tools for reviewing and analyzing test results remotely from the microscope. SoloWeb: A comprehensive web-based solution that enables remote analysis, reporting, and expert consultation on cases scanned using Bio-View's systems. Furthermore, Bio-View Ltd has established a strategic partnership with ANGLE plc to jointly develop a liquid biopsy circulating tumor cell HER2 assay, specifically targeting breast cancer.

Market cap$4M
Employees31
BIO VIEW competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Tvaster Genkalp and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Tvaster Genkalpand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →